Oncology
1 drug is in development for Vestibular Schwannoma.
- Companies
- 1
- Clinical trials
- 5
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Vestibular Schwannoma pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Preclinical(1)
| Drug | Company |
|---|---|
| ak-antivegf | Akouos, Inc. (AKUS) |
About this indication
Vestibular Schwannoma context
Oncology·MeSH: Neuroma, Acoustic (D009464)
Also known as: Acoustic Neurilemmoma, Acoustic Neurilemmomas, Acoustic Neurilemoma, Acoustic Neurilemomas, Acoustic Neurinoma, Acoustic Neurinomas, Acoustic Neuroma, Acoustic Neuromas, Acoustic Schwannoma, Acoustic Schwannomas, Acoustic Tumors, Neurinoma of the Acoustic Nerve, Schwannomas, Vestibular, Tumor, Acoustic
Frequently asked questions
How many drugs are in development for Vestibular Schwannoma?
BioSniper tracks 1 drug in development for Vestibular Schwannoma across 1 company.
How many clinical trials target Vestibular Schwannoma?
There are 5 clinical trials targeting Vestibular Schwannoma tracked by BioSniper.